Abstract: A stable blood factor composition contains a stabilizing amount of trehalose in the absence of human serum albumin to provide a product stable at up to 60° C.
Abstract: This invention relates to barrier methods for preserving sensitive biological materials as a porous foam, subsequently crushing the foam to form a powder, and optionally formulating mixtures of preserved powdered biological materials. The invention also encompasses an apparatus for integrating the methods of foam formation and subsequent crushing of the preserved biological materials using barrier technology.
Type:
Grant
Filed:
June 7, 2000
Date of Patent:
February 17, 2004
Assignee:
Quadrant Drug Delivery Limited
Inventors:
Victor Bronshtein, Kevin R. Bracken, Ronnie K. Livers, David R. Williams
Abstract: A stable blood factor composition contains a stabilising amount of trehalose in the absence of human serum albumin to provide a product stable at up to 60° C.